DrBrainRx review

What it is

DrBrainRx is a neurologist-led telehealth clinic founded by Dr. Sara Siavoshi, whose own description is that it specializes in GLP-1 medications and peptide therapies for weight loss and wellness. Its peptide side carries CJC-1295/ipamorelin, GHK-Cu and NAD⁺; its main line is compounded semaglutide and tirzepatide as weekly injections dispensed from USP-certified 503B pharmacies, with brand-name options available on a separate track. It is LegitScript certified, runs 100% online, and ships discreetly with tracking.

How it works

Fully online: a medical intake form, provider review typically inside 24 to 48 hours, then dispensing and shipping in about three to five business days with tracking. Ongoing care on the compounded track is bundled into a separate $25 monthly provider care fee covering dose titration, side-effect management and clinical messaging, described as cancellable at any time — an unusually explicit unbundling of clinical support from medication cost, which at least makes clear what you are paying for. The 503B sourcing is a genuine distinction worth understanding: 503B outsourcing facilities register with the FDA and operate under current good manufacturing practice requirements, which is a materially different oversight regime from 503A pharmacy compounding, even though the products themselves remain non-FDA-approved. What is missing is on the peptide side. No state list is published behind the nationwide presentation. Labs are neither required nor included, and no baseline bloodwork protocol is disclosed, which matters for CJC-1295/ipamorelin specifically. And no compounding pharmacy is named individually, only the 503B category.

Pricing transparency

Published for GLP-1 and absent for peptides. The compounded semaglutide vial is a flat $199 a month and tirzepatide a flat $299, explicitly the same at every dose — the site states the monthly price does not increase as the dose goes up — with a separate $25 monthly provider care fee on top on the compounded track, and a higher $99 monthly care fee on the brand-name track. Those are weight-loss figures. No price is published for CJC-1295/ipamorelin, GHK-Cu or NAD⁺, so we are not quoting one, and it would be wrong to read the $199 across. The structural lesson from the GLP-1 pricing is worth carrying into the peptide conversation anyway: this provider separates medication cost from care cost, so when you ask for a peptide price, ask whether the $25 care fee applies on top, whether the peptide price is flat across doses the way the GLP-1 pricing is, and what happens on refills.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Medication is described as dispensed from USP-certified US pharmacies, confirmed as 503B facilities, though no individual pharmacy is named — 503B registration is a meaningfully stronger sourcing signal than most of this board offers, but it does not make a compounded product an FDA-approved one. On the evidence, the three peptides on the wellness side are not equivalent. CJC-1295 and ipamorelin act on the growth-hormone axis, a genuine and well-described mechanism, but the long-term human outcome data stays thin and no controlled trial demonstrates the body-composition, recovery or anti-aging results they are marketed for. GHK-Cu has essentially no controlled human outcome evidence for the skin and recovery claims attached to it. Injected NAD⁺ has no controlled human outcome trials at all; the NAD⁺ forms with human data are the oral precursors NR and NMN, which reliably raise blood NAD⁺ — a raised biomarker rather than a demonstrated clinical outcome. On the GLP-1 side, the compounded products target the same receptors as branded semaglutide and tirzepatide but are not therapeutically equivalent to them, and the brand-name track is a separate, differently priced arrangement. Individual results vary.

Pros and watch-outs

The evidence behind what DrBrainRx prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Ipamorelin & CJC-1295: the honest evidence on GH secretagogue peptides

  They reliably raise growth hormone — that part is real. The muscle, fat-loss and anti-aging claims are not supported by human outcome data. A straight read.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

How DrBrainRx compares

A few alternatives worth a look, depending on what you’re optimizing for.

• SLSystem Labs

  NAD⁺ bundled with glutathione, B-12 and sermorelin from one service

  See System Labs →
• LHLuvo Health

  Prescription NAD⁺ as an injection, drops or nasal spray at one flat price

  See Luvo Health →
• Invigor Medical

  Prescription at-home NAD⁺ injections via telehealth

  See Invigor Medical →